Shanghai Labway Clinical Laboratory Co Ltd (301060) — Cash Flow Quality Index

Latest as of September 2025: 26.54x

Shanghai Labway Clinical Laboratory Co Ltd (301060) has a Cash Flow Quality Index of 26.54x as of September 2025. Operating cash flow of CN¥135.78 Million exceeds net income of CN¥5.12 Million, indicating high earnings quality where cash backs reported profits. Explore Shanghai Labway Clinical Laboratory Co L (301060) cash flow conversion to assess how effectively this company generates cash.

Cash Flow Quality Index

26.54x
Operating CF / Net Income

Operating Cash Flow

CN¥135.78 Million
CNY

Net Income

CN¥5.12 Million
CNY

Data as of

Sep 2025
Most recent filing

Shanghai Labway Clinical Laboratory Co Ltd Cash Flow Quality Index (2013–2022)

Historical Cash Flow Quality Index for Shanghai Labway Clinical Laboratory Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how aggressively does Shanghai Labway Clinical Laboratory Co L reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Shanghai Labway Clinical Laboratory Co Ltd (2013–2022)

Year-by-year earnings quality comparison for Shanghai Labway Clinical Laboratory Co Ltd. For live market cap and the full company financial profile, see 301060 market cap overview.

Year Quality Index Operating CF (CNY) Net Income YoY Change
2022 0.11x CN¥84.17 Million CN¥739.06 Million ▼ -86.7%
2021 0.85x CN¥223.51 Million CN¥261.62 Million ▼ -31.6%
2020 1.25x CN¥167.87 Million CN¥134.48 Million ▲ +67.3%
2019 0.75x CN¥70.60 Million CN¥94.61 Million ▼ -70.1%
2018 2.50x CN¥184.79 Million CN¥73.93 Million ▲ +441.3%
2016 0.46x CN¥27.14 Million CN¥58.76 Million ▼ -52.3%
2015 0.97x CN¥79.70 Million CN¥82.31 Million ▲ +182.3%
2014 -1.18x CN¥-82.77 Million CN¥70.34 Million ▼ -6188.7%
2013 0.02x CN¥1.63 Million CN¥84.34 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.